CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

Researchers delivered a dose of the “love hormone” oxytocin via a nasal spray to participants and found that it decreased ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.

J&J made it into a nasal spray to get it into the brain quickly ... they're feeling somewhat better" with Spravato. Spravato's warning label cautions about the risk of sedation and dissociation ...

Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand ... Downsides of Spravato: Spravato’s warning label cautions about the risk of sedation and dissociation, respiratory ...